{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:08:56Z","timestamp":1780463336082,"version":"3.54.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sirolimus (rapamycin), an antibiotic discovered in the 1970s, can effectively reduce allograft rejection, and plays an important role in the fields of immunosuppressive therapy and organ transplantation. Therefore, this study aimed to analyze adverse drug reactions (ADRs) associated with sirolimus using the FDA Adverse Event Reporting System (FAERS) database to inform clinical risk minimization strategies and guide safer therapeutic use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ADRs associated with sirolimus were retrospectively extracted from the FAERS database. Following the removal of duplicate entries, the final analytical dataset comprised 8,150,023 unique reports. Statistical analyses for signal detection of disproportionate reporting were performed using established pharmacovigilance metrics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 4,821 FAERS reports associated with sirolimus as the primary suspect drug were identified. Injury, poisoning and procedural complications (ROR\u00a0=\u00a01.61) \\are the most common reports, followed by investigation (ROR\u00a0=\u00a02.19), infections and infestations (ROR\u00a0=\u00a01.74). The top ADRs matched known profiles, including kidney transplant rejection (ROR\u00a0=\u00a0230.41). The analysis also revealed signals not prominently described in current prescribing information, including ovarian adenoma (ROR\u00a0=\u00a056.6), which should be interpreted cautiously as a hypothesis-generating pharmacovigilance signal rather than evidence of causality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This analysis details the ADR profile of sirolimus, revealing both known and potentially novel clinically significant adverse event signals that augment its known safety profile. Ongoing pharmacovigilance and targeted investigations are necessary to confirm these pharmacovigilance signals and inform optimal safety management strategies for sirolimus.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1780105","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:51:28Z","timestamp":1780462288000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A pharmacovigilance study of sirolimus-associated adverse events in organ transplantation"],"prefix":"10.3389","volume":"17","author":[{"given":"Da-Zhuang","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Scientific Research, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Feng","family":"Xiu","sequence":"additional","affiliation":[{"name":"Department of Cadre\u2019s Wards Ultrasound Diagnostics, Ultrasound Diagnostic Center, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Cadre\u2019s Wards Ultrasound Diagnostics, Ultrasound Diagnostic Center, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Long","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Orthopedic, Jilin Province Tumor Hospital","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cadre\u2019s Wards Ultrasound Diagnostics, Ultrasound Diagnostic Center, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cadre\u2019s Wards Ultrasound Diagnostics, Ultrasound Diagnostic Center, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf106","article-title":"Outcomes after solid organ transplantation in survivors of childhood, adolescent and young adult cancer: A population-based study","volume":"117","author":"Nathan","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.012272","article-title":"Review of the global activity of heart transplant","volume":"18","author":"El Rafei","year":"2025","journal-title":"Circ Heart Fail"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-024-00865-z","article-title":"Robotic kidney transplantation","volume":"21","author":"Basile","year":"2024","journal-title":"Nat Rev Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000745","article-title":"Xenotransplantation: Current understanding of the mechanism of immune-mediated injury","volume":"36","author":"Tatapudi","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03568-z","article-title":"LILRB3 genetic variation is associated with kidney transplant failure in African American recipients","volume":"31","author":"Sun","year":"2025","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3640","article-title":"Night-time chronotherapy with methylprednisolone prevents an acute rejection in pediatric patients with liver transplantation: A randomized clinical trial","volume":"118","author":"Ushijima","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2024.11.033","article-title":"Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohort","volume":"44","author":"Rim","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16505","article-title":"Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis","volume":"21","author":"Ehx","year":"2021","journal-title":"Am J Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: a review of the evidence","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.molcel.2025.05.003","article-title":"YTHDF1 differentiates the contributing roles of mTORC1 in aging","volume":"85","author":"Xu","year":"2025","journal-title":"Mol Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.amjcard.2024.12.015","article-title":"Predictors and long-term prognostic significance of bailout stenting during percutaneous coronary interventions with sirolimus-coated balloon: A subanalysis of the Eastbourne study","volume":"239","author":"Gurgoglione","year":"2025","journal-title":"Am J Cardiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202255299","article-title":"Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster","volume":"23","author":"Aiello","year":"2022","journal-title":"EMBO Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.70211","article-title":"Calcineurin inhibitor replacement with mammalian target of rapamycin (mTOR) inhibitor following lung transplantation","volume":"39","author":"Kommaraju","year":"2025","journal-title":"Clin Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"102261","DOI":"10.1016\/j.jvsv.2025.102261","article-title":"Oral sirolimus therapy for patients with complex low-flow vascular malformations","volume":"13","author":"Nisbet","year":"2025","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"B15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/jrms.jrms_531_22","article-title":"The side effect profile of sirolimus and its relationship with some variables: A retrospective study of Iranian renal transplant patients","volume":"28","author":"Shahidi","year":"2023","journal-title":"J Res Med Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70055","article-title":"Real-world case supporting drug-induced autoimmune hepatitis: Updated insights and analysis of the FAERS data","volume":"45","author":"Huang","year":"2025","journal-title":"Liver Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.02.072","article-title":"Reported psychiatric adverse events among isotretinoin users: Monitoring priorities from a 20-year FAERS database study","volume":"93","author":"Nie","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA adverse event reporting system","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int J Med Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000002592","article-title":"Unveiling the hidden risks: analysis of adverse drug reactions associated with probiotics from the FAERS database - quality improvement study","volume":"111","author":"Jiao","year":"2025","journal-title":"Int J Surg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13959","article-title":"Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long-term benefits","volume":"34","author":"Andres","year":"2021","journal-title":"Transpl Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2020.02.159","article-title":"Determinants of successful use of sirolimus in renal transplant patients","volume":"52","author":"Naik","year":"2020","journal-title":"Transplant Proc"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12572","article-title":"Alemtuzumab and sirolimus in renal transplantation: six-year results of a single-arm prospective pilot study","volume":"14","author":"Sutherland","year":"2014","journal-title":"Am J Transplant"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181613e65","article-title":"Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantation","volume":"85","author":"Smith","year":"2008","journal-title":"Transplantation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/403280","article-title":"Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors","volume":"2013","author":"Zaza","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.07.003","article-title":"Sirolimus as rescue therapy after liver transplantation","volume":"44","author":"Reigada","year":"2012","journal-title":"Transplant Proc"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2012.719874","article-title":"An evaluation of sirolimus in renal transplantation","volume":"8","author":"Halleck","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1780105\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:51:34Z","timestamp":1780462294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1780105\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":26,"alternative-id":["10.3389\/fimmu.2026.1780105"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1780105","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1780105"}}